Impact of substance abuse on the course and treatment of bipolar disorder

Bipolar Disorders

Volumn 2, Issue 3 PART 2, 2000, Pages 269-280

  Salloum, Ihsan M ^a   Thase, Michael E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alcoholism; Bipolar disorder; Comorbidity; Manic depression; Psychoactive substance use disorders (PSUDs)

Indexed keywords

PSYCHOTROPIC AGENT; TRANQUILIZER;

ADDICTION; ALCOHOLISM; BIPOLAR DISORDER; COMORBIDITY; HUMAN; MULTIMODALITY CANCER THERAPY; REVIEW; TREATMENT OUTCOME;

ALCOHOLISM; ANTIMANIC AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 0034278718     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2000.20308.x     Document Type: Review

References (121)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
2. Kraepelin E. In: Robertson GM, ed. Manic-Depressive Insanity and Paranoia. Translated by RM Barclay. Edinburgh: E & S Livingstone, 1921. Reprinted New York: Arno Press, 1921.
3. Miller FT, Busch F, Tanenbaum JH. Drug abuse in schizophrenia and bipolar disorder. Am J Drug Alcohol Abuse 1989; 15(3): 291-295.
4. Bernadt MW, Murray RM. Psychiatric disorder, drinking and alcoholism: what are the links? Br J Psychiatr 1986 Apr; 148: 393-400.
5. Hasin D, Endicott J, Lewis C. Alcohol and drug abuse in patients with affective syndromes. Compr Psychiatr 1985; 26 (3): 283-295.
6. Estroff TW, Dackis CA, Gold MS, Pottash AL. Drug abuse and bipolar disorders. Int J Psychiatr Med 1985; 15 (1): 37-40.
7. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RM. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986 Jun 13; 255 (22): 3138-3142.
8. Weissman MM, Myers JK. Clinical depression in alcoholism. Am J Psychiatr 1980 Mar; 137 (3): 372-373.
9. Brown R. U.S. experience with valproate in manic depressive illness: a multicenter trial. [Review] [16 refs]. J Clin Psychiatr 1989 Mar; 50 Suppl: 13-16.
10. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatr 1988 Nov; 45 (11): 1023-1031.
11. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatr 1985 Nov; 42 (11): 1050-1055.
12. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study [see comments]. JAMA 1990 Nov 21; 264 (19): 2511-2518.
13. Kessler RC, Crum RM, Warner LA, Nelson CB et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatr 1997 Apr; 54 (4): 313-321.
14. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatr 1999; 60 (11): 733-740.
15. Mirin SM, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug abusers and their families. Compr Psychiatr 1991 Jan-Feb 28; 32 (1): 36-51.
16. Weiss RD, Mirin SM, Michael JL, Sollogub AC. Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse 1986; 12 (1-2): 17-29.
17. Gawin F, Kleber H. Pharmacologic treatments of cocaine abuse. [Review] [53 refs]. Psychiatr Clin North Am 1986 Sep; 9 (3): 573-583.
18. Nunes EV, Quitkin FM, Klein DF. Psychiatric diagnosis in cocaine abuse. Psychiatr Res 1989 Apr; 28 (1): 105-114.
19. Griffin ML, Weiss RD, Mirin SM, Lange U. A comparison of male and female cocaine abusers [see comments]. Arch Gen Psychiatr 1989 Feb; 46 (2): 122-126.
20. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatr 1998 Jan; 55 (1): 41-46.
21. Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatr 1998 May; 155 (5): 646-652.
22. Black DW, Winokur G, Nasrallah A. Is death from natural causes still excessive in psychiatric patients? A follow-up of 1593 patients with major affective disorder. J Nerv Ment Dis 1987 Nov; 175 (11): 674-680.
23. Himmelhoch JM. Mixed states, manic-depressive illness, and the nature of mood. Psychiatric Clin North Am 1979; 2: 449-459.
24. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatr 1976 Sep; 33 (9): 1062-1066.
25. Strakowski SM, Keck PE Jr, McElroy SL, West SA, Sax KW, Hawkins JM, Kmetz GF, Upadhyaya VH, Tugrul KC, Bourne ML. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatr 1998 Jan; 55 (1): 49-55.
26. Brady KT, Lydiard RB. Bipolar affective disorder and substance abuse. J Clin Psychopharmacol 1992 Feb; 12 (1): 17S-22S.
27. Post RM, Kopanda RT. Cocaine, kindling, and psychosis. [Review] [100 refs]. Am J Psychiatr 1976 Jun; 133 (6): 627-634.
28. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994 Jun; 182 (6): 349-352.
29. Winokur G, Coryell W, Akiskal HS, Maser JD, Keller MB, Endicott J, Mueller T. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary secondary distinction. Am J Psychiatr 1995 Mar; 152 (3): 365-372.
30. Satel SL, Kosten TR, Schuckit MA, Fischman MW. Should protracted withdrawal from drugs be included in DSM-IV? [see comments] [Review] [109 refs]. Am J Psychiatr 1993 May; 150 (5): 695-704.
31. Nofzinger E, Buysse D, Reynolds CE, Kupfer DJ. Sleep disorders related to another mental disorder (non-substance/primary): a DSM-IV literature review. [Review] [155 refs]. J Clin Psychiatr 1993 Jul; 54 (7): 244-255.
32. Clark CP, Gillin JC, Golshan S, Demodena A, Smith TL, Danowski S, Irwin M, Schuckit M. Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatr 1998 Apr 15; 43 (8): 601-607.
33. Tohen M, Waternaux CM, Tsuang MT, Hunt AT. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord 1990 Jun; 19 (2): 79-86.
34. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatr 1990 Dec; 47 (12): 1106-1111.
35. Reich LH, Davies RK, Himmelhoch JM. Excessive alcohol use in manic-depressive illness. Am J Psychiatr 1974 Jan; 131 (1): 83-86.
36. Emrich HM. Treatment of therapy-resistant depression with drip infusions of chlomipramine. In: Zohar J, Belmaker RH, eds. Treating Resistant Depression. New York: PMA Publishing Corp, 1987; 389-396.
37. Kessing LV. Recurrence in affective disorder: II. Effect of age and gender. Br J Psychiatr 1998 Jan; 172: 29-34.
38. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatr 1995; 56 (Suppl 3): 19-24.
39. Dilsaver SC. The pathophysiologies of substance abuse and affective disorders: an integrative model? [Review] [121 refs]. J Clin Psychopharmacol 1987 Feb; 7 (1): 1-10.
40. Salloum IM, Cornelius JR, Mezzich JE, Daley DC, Kirisci L, Spotts CR. Impact of Pathological Alcohol Use on Acute Mania. Paper presented at The Annual Meeting of the American Psychiatric Association, 15 May, Washington, DC. 1999.
41. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L, Daley DC, Spotts CR. Bipolar Disorder with Alcohol Abuse: Impact on Symptom Presentation. Paper presented at 38th NCDEU Annual Meeting, 1-4 June, Boca Raton, FL. 1998.
42. Mayfield D. Substance abuse in the affective disorders. In: Alterman A, ed. Substance Abuse and Psychopathology. New York: Plenum Press, 1985; 69-90.
43. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L, Daley DC, Spotts CR. Differential symptom presentation among female patients with comorbid bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 1999; 23 (5): 131A.
44. Morrison JR. Bipolar affective disorder and alcoholism. Am J Psychiatr 1974 Oct; 131 (10): 1130-1133.
45. Bunney WE Jr, Goodwin FK, Murphy DL. The "switch process" in manic-depressive illness. 3. Theoretical implications. Arch Gen Psychiatr 1972 Sep; 27 (3): 312-317.
46. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986; 22 (3): 613-620.
47. Cloninger CR, Reich T. Genetic heterogeneity in alcoholism and sociopathy. [Review] [90 refs]. Res Publ Assoc Res Nerv Ment Dis 1983; 60: 145-166.
48. Bukstein OG. Aggression, violence, and substance abuse in adolescents. Child Adolesc Psychiatr Clin North Am 1996; 5: 93-109.
49. Bukstein OG, Brent DA, Kaminer Y. Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatr 1989 Sep; 146 (9): 1131-1141.
50. Clark DB, Neighbors B. Adolescent psychoactive substance abuse and internalizing disorders. Child Adolesc Psychiatr Clin North Am 1996; 5: 45-57.
51. Wilens TE, Biederman J, Spencer TJ. Attention deficit hyperactivity disorder and the psychoactive substance use disorders. Child Adolesc Psychiatr Clin North Am 1996; 5: 73-91.
52. Wilens TE, Biederman J, Millstein RB, Wozniak J, Hahesy AL, Spencer TJ. Risk for substance use disorders in youths with child-and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatr 1999 Jun; 38 (6): 680-685.
53. Winokur G, Clayton PJ, Reich T. Manic Depressive Illness. St Louis, MO: Mosby-Year Book Inc, 1969.
54. Liskow B, Mayfield D, Thiele J. Alcohol and affective disorder: assessment and treatment. J Clin Psychiatr 1982 Apr; 43 (4): 144-147.
55. Mayfield DG, Coleman LL. Alcohol use and affective disorder. Dis Nerv Syst 1968 Jul; 29 (7): 467-474.
56. Zisook S, Schuckit MA. Male primary alcoholics with and without family histories of affective disorder. J Stud Alcohol 1987 Jul; 48 (4): 337-344.
57. Huizinga DH, Menard S, Elliott DS. Delinquency and drug use: temporal and developmental patterns. Justice Q 1989; 6: 419-455.
58. Robins LN, McEvoy L. Conduct problems as predictors of substance abuse. In: Robins L, Rutter M, eds. Straight and Devious Pathways From Childhood to Adulthood. New York: Cambridge University Press, 1990.
59. Rohde P, Lewinsohn PM, Seeley JR. Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatr 1996; 35: 101-109.
60. Biederman J, Faraone S, Mick E, Wozniak J et al. Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatr 1996 Aug; 35 (8): 997-1008.
61. Biederman J, Wilens T, Mick E, Milberger S et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatr 1995 Nov; 152 (11): 1652-1658.
62. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatr 1997 Sep; 36 (9): 1168-1176.
63. Sanchez L, Hagino O, Weller E, Weller R. Bipolarity in children. Psychiatric Clin North Am 1999; 22 (3): 629-644.
64. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatr 1985 Nov; 142 (11): 1259-1264.
65. Weiss RD, Mirin SM. Substance abuse as an attempt at self-medication. Psychiatric Med 1987; 3: 357-367.
66. Fontana DJ, Post RM, Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 1993 Nov; 629 (1): 31-39.
67. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatr 1986; 149: 191-201.
68. Post RM, Weiss SRB. Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol Psychiatr 1998 Aug; 44 (3): 193-206.
69. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatr 1992 Aug; 149 (8): 999-1010.
70. Goldberg JF, Harrow M. Kindling in bipolar disorders: a longitudinal follow-up study. Biol Psychiatr 1994 Jan 1; 35 (1): 70-72.
71. Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatr 1978; 133: 1-14.
72. Koch-Weser J, Sellers EM, Kalant H. Alcohol intoxication and withdrawal. [Review] [34 refs]. New Engl J Med 1976 Apr 1; 294 (14): 757-762.
73. McCown TJ, Breese GR. Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 1990; 14 (3): 394-399.
74. Ulrichsen J, Clemmesen L, Hemmingsen R. Convulsive behaviour during alcohol dependence: discrimination between the role of intoxication and withdrawal. Psychopharmacology 1992; 107 (1): 97-102.
75. Lechtenberg R, Worner TM. Relative kindling effect of detoxification and non-detoxification admission in alcoholics. Alcohol Alcoholism 1991; 26 (2): 221-225.
76. Brown ME, Anton RF, Malcolm R, Ballenger JC. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatr 1988 Mar; 23 (5): 507-514.
77. Nutt DJ, Glue P. Neurochemical insights into alcohol kindling. Hum Psychopharmacol Clin Exp 1989; 4 (3): 157-158.
78. Glue P, Nutt DJ. Overexcitement and disinhibition: dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatr 1990; 157: 491-499.
79. Collingridge GL, Lester RAJ. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 1989; 40: 143-210.
80. 3H]aspartate efflux oscillate with repeated treatment. Relevance to individual differences in drug responsiveness. Neuropsychopharmacology 1996 Aug; 15 (2): 125-132.
81. Kucinski BJ, Antelman SM, Caggiula AR, Fowler H, Gershon S, Edwards DJ. Cocaine-induced oscillation is conditionable. Pharmacol Biochem Behav 1999 Jul; 63 (3): 449-455.
82. Antelman SM, Gershon S. Clinical application of time-dependent sensitization to antidepressant therapy. [Review] [40 refs]. Prog Neuro-Psychopharmacol Biol Psychiatr 1998 Jan; 22 (1): 65-78.
83. Antelman SM. Time-dependent sensitization in animals: a possible model of multiple chemical sensitivity in humans. [Review] [35 refs]. Toxicol Ind Health 1994 Jul-Oct 10; 31 (4-5): 335-342.
84. Crowe RR. The genetics of panic disorder and agoraphobia. Psychiatr Dev 1985; 3: 171-185.
85. Leshner AI, Koob GF. Drugs of abuse and the brain. [Review] [83 refs]. Proc Assoc Am Physicians 1999 Mar 30-Apr 30; 111 (2): 99-108.
86. Depue RA, Spoont MR. Conceptualizing a serotonin trait. A behavioral dimension of constraint. Ann NY Acad Sci 1986; 487: 47-62.
87. Koob GF, Nestler EJ. The neurobiology of drug addiction. [Review] [169 refs]. J Neuropsychiatr Clin Neurosci 1997 Summer; 9 (3): 482-497.
88. Prange AJ Jr, Wilson IC, Lynn CW, Alltop LB, Stike-leather RA. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch Gen Psychiatr 1974 Jan; 30 (1): 56-62.
89. Tabakoff B, Hoffman PL. Alcohol: neurobiology. In: Lowinson JH, Ruiz P, Millman RB et al., eds. Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams & Wilkins, 1992; 152-186.
90. Samson HH, Tolliver GA, Schwartz-Stevens K. Oral ethanol self-administration: a behavioral pharmacological approach to CNS control mechanisms. Alcohol 1990 May-Jun; 7 (3): 187-191.
91. Kling MA, Kellner CH, Post RM, Cowdry RW, Gardner DL, Coppola R, Putnam FW, Gold PW. Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: relevance to the pathophysiology of affective dysregulation in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatr 1987; 11: 459-481.
92. Petty F. GABA and mood disorders: a brief review and hypothesis. [Review] [60 refs]. J Affect Disord 1995 Aug 18; 34 (4): 275-281.
93. Bernasconi R. The GABA hypothesis of affective illness: influence of clinically effective antimanic drugs on GABA turnover. In: Emrich HM, Aldenhoff JB, Lux HD, eds. Basic Mechanisms in the Action of Lithium. Amsterdam: Excerpta Medica, 1982.
94. Petty F, Kramer GL, Fulton M, Moeller FG, Rush AJ. Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacology 1993 Sep; 9 (2): 125-132.
95. Meyer RE, Schildkraut JJ, Mirin SM, Orsulak PJ, Randall M, McDougle M, Platz PA, Grab E, Babor T. Opiates, catecholamines, behavior, and mood. Psychopharmacology 1978 Apr; 56 (3): 327-333.
96. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. [Review] [63 refs]. Science 1997 Oct 3; 278 (5335): 58-63.
97. Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatr 1997 Aug; 54 (8): 737-742.
98. Mason B. Medical allies against alcoholism. Health News 1999 Jun 25; 5 (8): 3-4.
99. Berger PA, Barchas JD. Pharmacologic studies of beta-endorphin in psychopathology. [Review] [51 refs]. Psychiatric Clin North Am 1983 Sep; 6 (3): 377-391.
100. Willner P, Golembiowska K, Klimek V, Muscat R. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 1991; 19 (1): 122-126.
101. Weiss RD, Najavits LM. Overview of treatment modalities for dual diagnosis patients: pharmacotherapy, psychotherapy, and 12-step programs. In: Kranzler H, Rounsaville H, Bruce J, eds. Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders, xiii ed. New York: Marcel Dekker, 1998; 107-137.
102. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatr 1998 Apr; 59 (4): 172-174.
103. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Spotts CR. Differential Pattern of Alcohol Use Profile Among Bipolar Alcoholics. Paper presented at the 10th Annual Meeting of the American Academy of Addiction Psychiatry, 3 December, Nassau, Bahamas. 1999.
104. Weiss RD, Najavits LM, Greenfield SF. A relapse prevention group for patients with bipolar and substance use disorders. J Subst Abuse Treat 1999 Jan; 16 (1): 47-54.
105. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression [see comments]. JAMA 1996 Mar 13; 275 (10): 761-767.
106. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, Quitkin FM. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatr 1996 Mar; 53 (3): 232-240.
107. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Black A, Perel JM, Thase ME. Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacol Bull 1997; 33(1): 165-170.
108. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. [Review] [56 refs]. J Clin Psychopharmacol 1992 Feb; 12 (Suppl 1): 36S-41S.
109. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Valproate in the treatment of bipolar disorder: literature review and clinical guidelines. [Review] [73 refs]. J Clin Psychopharmacol 1992 Feb; 12 (Suppl 1): 42S-52S.
110. Meldrum B. Pharmacology of GABA. [Review] [187 refs]. Clin Neuropharmacol 1982; 5 (3): 293-316.
111. Rosenthal RN, Perkel C, Singh P, Anand O, Miner CR. A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict 1998 Summer; 7 (3): 189-197.
112. Wilder BJ. Pharmacokinetics of valproate and carbamazepine. J Clin Psychopharmacol 1992 Feb; 12 (Suppl 1): 64S-68S.
113. Hillbom M, Tokola R, Kuusela V, Karkkainen P, KalliLemma L, Pilke A, Kaste M. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 1989 May-Jun 30; 6 (3): 223-226.
114. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. [Review] [84 refs]. J Clin Psychiatr 1989 Nov; 50 (11): 403-412.
115. Keck PEJ, McElroy SL, Vuckovic A, Friedman LM. Combined valproate and carbamazepine treatment of bipolar disorder. J Neuropsychiatr Clin Neurosci 1992 Summer; 4 (3): 319-322.
116. Rohsenow DJ, Niaura RS, Childress AR, Abrams DB, Monti PM. Cue reactivity in addictive behaviors: theoretical and treatment implications. Int J Addict 1990; 25 (7A-8A): 957-993.
117. Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992 Feb; 12 (Suppl 1): 53-56.
118. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J, Williams M, Heath J. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency [see comments]. J Am Acad Child Adolesc Psychiatr 1998 Feb; 37 (2): 171-178.
119. Litten RZ, Allen JP. Pharmacologic treatment of alcoholics with collateral depression: issues and future directions. [Review] [24 refs]. Psychopharmacol Bull 1998; 34 (1): 107-110.
120. Salloum IM, Cornelius JR, Thase ME, Daley DC, Kirisci L, Spotts C. Naltrexone utility in depressed alcoholics. Psychopharmacol Bull 1998; 34 (1): 111-115.
121. Salloum IM, Cornelius JR. Management of side effects of drugs used in treatment of alcoholism and drug abuse. In: Balon R, ed. Practical Management of the Side Effects of Psychotropic Drugs. New York: Marcel Dekker, 1999; 169-197.